SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-20-003834
Filing Date
2020-03-17
Accepted
2020-03-17 17:22:38
Documents
1
Period of Report
2020-03-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3983
  Complete submission text file 0001179110-20-003834.txt   5369
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Issuer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KINIKSA PHARMACEUTICALS CORP. 100 HAYDEN AVENUE LEXINGTON MA 02421
Business Address
Rizvi Qasim (Reporting) CIK: 0001794636 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38492 | Film No.: 20722093